| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $2.68 | $2.42 | $2.72 | $2.33 | $2.16 | $1.60 | $2.01 | $1.95 |
| EPS (Diluted) | $2.66 | $2.40 | $2.69 | $2.30 | $2.14 | $1.59 | $2.00 | $1.93 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.1B | $18.6B | $17.5B | $17.0B | $16.3B | $16.0B | $14.5B | $14.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $18.4B | $16.1B | $15.3B | $15.0B | $14.1B | $13.7B | $12.3B | $11.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.8B | $2.4B | $2.3B | $2.0B | $2.3B | $2.3B | $2.2B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.5B | $0.2B | $0.4B | $0.1B | $0.2B | $0.3B |
| Investing Cash Flow | $-0.5B | $-1.0B | $-0.7B | $-0.9B | $-0.5B | $-1.2B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.2B | $0.7B | $0.2B | $0.7B | $0.1B | $1.1B | $0.0B | $0.0B |